Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.79 USD | +6.46% | +2.71% | +79.62% |
03-19 | Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants | MT |
03-15 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Sales 2024 * | 54.24M 4.34B | Sales 2025 * | 230M 18.44B | Capitalization | 2.23B 179B |
---|---|---|---|---|---|
Net income 2024 * | -214M -17.13B | Net income 2025 * | -110M -8.81B | EV / Sales 2024 * | 38.5 x |
Net cash position 2024 * | 142M 11.36B | Net cash position 2025 * | 121M 9.67B | EV / Sales 2025 * | 9.16 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-22.3
x | Employees | 141 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.91% |
Latest transcript on Geron Corporation
1 day | +6.46% | ||
1 week | +2.71% | ||
Current month | +14.85% | ||
1 month | +14.85% | ||
3 months | +75.46% | ||
6 months | +108.24% | ||
Current year | +79.62% |
Managers | Title | Age | Since |
---|---|---|---|
John Scarlett
CEO | Chief Executive Officer | 73 | 28/09/11 |
Director of Finance/CFO | 57 | 24/09/23 | |
Faye Feller
CTO | Chief Tech/Sci/R&D Officer | 42 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
V. Lawlis
BRD | Director/Board Member | 72 | 14/03/12 |
John Scarlett
CEO | Chief Executive Officer | 73 | 28/09/11 |
Susan Molineaux
BRD | Director/Board Member | 70 | 27/09/12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.79 | +6.46% | 7,876,644 |
25/04/24 | 3.56 | -0.56% | 9,073,265 |
24/04/24 | 3.58 | +2.29% | 6,966,977 |
23/04/24 | 3.5 | -6.17% | 10,388,428 |
22/04/24 | 3.73 | +1.08% | 8,217,024 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.62% | 2.23B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- GERN Stock